Guo J - Search Results

1

PD-L1 on dendritic cells attenuates T cell activation and regulates response to immune checkpoint blockade.

Peng Q, Qiu X, Zhang Z, Zhang S, Zhang Y, Liang Y, Guo J, Peng H, Chen M, Fu YX, Tang H. Peng Q, et al. Among authors: guo j. Nat Commun. 2020 Sep 24;11(1):4835. doi: 10.1038/s41467-020-18570-x. Nat Commun. 2020. PMID: 32973173 Free PMC article.

2

Innate lymphotoxin receptor mediated signaling promotes HSV-1 associated neuroinflammation and viral replication.

Liang Y, Yang K, Guo J, Wroblewska J, Fu YX, Peng H. Liang Y, et al. Among authors: guo j. Sci Rep. 2015 May 20;5:10406. doi: 10.1038/srep10406. Sci Rep. 2015. PMID: 25993659 Free PMC article.

3

Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade.

Tang H, Wang Y, Chlewicki LK, Zhang Y, Guo J, Liang W, Wang J, Wang X, Fu YX. Tang H, et al. Among authors: guo j. Cancer Cell. 2016 Mar 14;29(3):285-296. doi: 10.1016/j.ccell.2016.02.004. Cancer Cell. 2016. PMID: 26977880 Free PMC article.

4

CTLA-4 Limits Anti-CD20-Mediated Tumor Regression.

Ren Z, Guo J, Liao J, Luan Y, Liu Z, Sun Z, Liu X, Liang Y, Peng H, Fu YX. Ren Z, et al. Among authors: guo j. Clin Cancer Res. 2017 Jan 1;23(1):193-203. doi: 10.1158/1078-0432.CCR-16-0040. Epub 2016 Jun 27. Clin Cancer Res. 2017. PMID: 27354469 Free PMC article.

5

Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade.

Tang H, Wang Y, Chlewicki LK, Zhang Y, Guo J, Liang W, Wang J, Wang X, Fu YX. Tang H, et al. Among authors: guo j. Cancer Cell. 2016 Sep 12;30(3):500. doi: 10.1016/j.ccell.2016.08.011. Epub 2016 Sep 12. Cancer Cell. 2016. PMID: 27622338 Free article. No abstract available.

6

Vaccines targeting preS1 domain overcome immune tolerance in hepatitis B virus carrier mice.

Bian Y, Zhang Z, Sun Z, Zhao J, Zhu D, Wang Y, Fu S, Guo J, Liu L, Su L, Wang FS, Fu YX, Peng H. Bian Y, et al. Among authors: guo j. Hepatology. 2017 Oct;66(4):1067-1082. doi: 10.1002/hep.29239. Epub 2017 Aug 26. Hepatology. 2017. PMID: 28445927 Free PMC article. Clinical Trial.

7

PD-L1 on host cells is essential for PD-L1 blockade-mediated tumor regression.

Tang H, Liang Y, Anders RA, Taube JM, Qiu X, Mulgaonkar A, Liu X, Harrington SM, Guo J, Xin Y, Xiong Y, Nham K, Silvers W, Hao G, Sun X, Chen M, Hannan R, Qiao J, Dong H, Peng H, Fu YX. Tang H, et al. Among authors: guo j. J Clin Invest. 2018 Feb 1;128(2):580-588. doi: 10.1172/JCI96061. Epub 2018 Jan 16. J Clin Invest. 2018. PMID: 29337303 Free PMC article.

8

Salivary factor LTRIN from Aedes aegypti facilitates the transmission of Zika virus by interfering with the lymphotoxin-β receptor.

Jin L, Guo X, Shen C, Hao X, Sun P, Li P, Xu T, Hu C, Rose O, Zhou H, Yang M, Qin CF, Guo J, Peng H, Zhu M, Cheng G, Qi X, Lai R. Jin L, et al. Among authors: guo j, guo x. Nat Immunol. 2018 Apr;19(4):342-353. doi: 10.1038/s41590-018-0063-9. Epub 2018 Mar 5. Nat Immunol. 2018. PMID: 29507355

9

Dual Targeting of Innate and Adaptive Checkpoints on Tumor Cells Limits Immune Evasion.

Liu X, Liu L, Ren Z, Yang K, Xu H, Luan Y, Fu K, Guo J, Peng H, Zhu M, Fu YX. Liu X, et al. Among authors: guo j. Cell Rep. 2018 Aug 21;24(8):2101-2111. doi: 10.1016/j.celrep.2018.07.062. Cell Rep. 2018. PMID: 30134171 Free article.

10

Targeting IFNα to tumor by anti-PD-L1 creates feedforward antitumor responses to overcome checkpoint blockade resistance.

Liang Y, Tang H, Guo J, Qiu X, Yang Z, Ren Z, Sun Z, Bian Y, Xu L, Xu H, Shen J, Han Y, Dong H, Peng H, Fu YX. Liang Y, et al. Among authors: guo j. Nat Commun. 2018 Nov 2;9(1):4586. doi: 10.1038/s41467-018-06890-y. Nat Commun. 2018. PMID: 30389912 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

31,344 results

Search Page

Filters